The global hemoglobin A1C analyzer market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and its complications, which are driving the demand for hemoglobin A1C analyzers. The increasing number of patients with diabetes and its complications is also driving the demand for hemoglobin A1C analyzers in hospitals and laboratories.
The global hemoglobin A1C analyzer market by type can be segmented into benctop and portable devices. The benctop segment accounted for a share of over 50% in 2018, owing to their high accuracy levels as compared with portable devices. However, due to their higher cost as compared with portable devices, they are used only in hospitals or laboratories where accuracy levels are critical such as blood banks or research labs. Portable devices accounted for a share of over 50% in 2018 owing to their lower cost as compared with benctop devices; they are used by physicians who need accurate results on-the-spot such as general practitioners or endocrinologists who diagnose diabetes mellitus cases on an outpatient basis.
The global hemoglobin A1C analyzer market by application can be segmented into hospital and laboratory applications; it was dominated by hospital applications in 2018 owing to the high prevalence rates among diabetic patients admitted at hospitals than those diagnosed outside hospitals (elderly population). Hospital applications accounted for a share of over 60% in 2018 while laboratory applications accounted for less than 40%.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of diabetes and obesity in the population will drive the growth of the Hemoglobin A1C Analyzer market.
- Increasing awareness about diabetes and its complications will also drive the growth of the Hemoglobin A1C Analyzer market.
- The increasing number of clinical trials for new drugs to treat diabetes will also fuel the growth of this market.
- The high cost associated with these devices may hamper their adoption.
Industry Growth Insights published a new data on “Hemoglobin A1C Analyzer Market”. The research report is titled “Hemoglobin A1C Analyzer Market research by Types (Bench-top, Portable), By Applications (Hospital, Lab, Other), By Players/Companies Abbott, Siemens, Roche, Trinity Biotech, EKF Diagnostics, OSANG Healthcare, Erba Diagnostics, DiaSys Diagnostic, GreenCross, PTS Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoglobin A1C Analyzer Market Research Report
By Type
Bench-top, Portable
By Application
Hospital, Lab, Other
By Companies
Abbott, Siemens, Roche, Trinity Biotech, EKF Diagnostics, OSANG Healthcare, Erba Diagnostics, DiaSys Diagnostic, GreenCross, PTS Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Hemoglobin A1C Analyzer Market Report Segments:
The global Hemoglobin A1C Analyzer market is segmented on the basis of:
Types
Bench-top, Portable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Lab, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Siemens
- Roche
- Trinity Biotech
- EKF Diagnostics
- OSANG Healthcare
- Erba Diagnostics
- DiaSys Diagnostic
- GreenCross
- PTS Diagnostics
Highlights of The Hemoglobin A1C Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bench-top
- Portable
- By Application:
- Hospital
- Lab
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoglobin A1C Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemoglobin A1C Analyzer is a laboratory device that measures the average blood sugar level over the past two to three months. Hemoglobin A1C levels above 6.5% are considered diabetes, and levels above 7% indicate prediabetes.
Some of the key players operating in the hemoglobin a1c analyzer market are Abbott, Siemens, Roche, Trinity Biotech, EKF Diagnostics, OSANG Healthcare, Erba Diagnostics, DiaSys Diagnostic, GreenCross, PTS Diagnostics.
The hemoglobin a1c analyzer market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemoglobin A1C Analyzer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemoglobin A1C Analyzer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemoglobin A1C Analyzer Market - Supply Chain
4.5. Global Hemoglobin A1C Analyzer Market Forecast
4.5.1. Hemoglobin A1C Analyzer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemoglobin A1C Analyzer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemoglobin A1C Analyzer Market Absolute $ Opportunity
5. Global Hemoglobin A1C Analyzer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
5.3.1. Bench-top
5.3.2. Portable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemoglobin A1C Analyzer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Lab
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemoglobin A1C Analyzer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemoglobin A1C Analyzer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemoglobin A1C Analyzer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemoglobin A1C Analyzer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemoglobin A1C Analyzer Demand Share Forecast, 2019-2026
9. North America Hemoglobin A1C Analyzer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Lab
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
9.7.1. Bench-top
9.7.2. Portable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemoglobin A1C Analyzer Demand Share Forecast, 2019-2026
10. Latin America Hemoglobin A1C Analyzer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Lab
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
10.7.1. Bench-top
10.7.2. Portable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemoglobin A1C Analyzer Demand Share Forecast, 2019-2026
11. Europe Hemoglobin A1C Analyzer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemoglobin A1C Analyzer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Lab
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
11.7.1. Bench-top
11.7.2. Portable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemoglobin A1C Analyzer Demand Share, 2019-2026
12. Asia Pacific Hemoglobin A1C Analyzer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemoglobin A1C Analyzer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Lab
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
12.7.1. Bench-top
12.7.2. Portable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemoglobin A1C Analyzer Demand Share, 2019-2026
13. Middle East & Africa Hemoglobin A1C Analyzer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemoglobin A1C Analyzer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemoglobin A1C Analyzer Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Lab
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemoglobin A1C Analyzer Market Size and Volume Forecast by Type
13.7.1. Bench-top
13.7.2. Portable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemoglobin A1C Analyzer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemoglobin A1C Analyzer Market: Market Share Analysis
14.2. Hemoglobin A1C Analyzer Distributors and Customers
14.3. Hemoglobin A1C Analyzer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Trinity Biotech
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. EKF Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. OSANG Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Erba Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DiaSys Diagnostic
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GreenCross
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. PTS Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
